Description

Product Overview

The CA19-9 Test Kit is a fluorescence immunoassay designed for quantitative determination of CA19-9 tumor marker levels. CA19-9 is widely used in monitoring pancreatic cancer progression and therapeutic response. Quantitative measurement supports clinical evaluation of gastrointestinal malignancies.

Intended Use

For in vitro quantitative determination of CA19-9 in serum, plasma or whole blood as an aid in diagnosis and monitoring of pancreatic cancer.

Clinical Significance

Supports pancreatic cancer monitoring, evaluates treatment response, assists prognosis assessment and helps detect gastrointestinal tumor activity.

Test Principle

Sandwich fluorescence immunoassay using labelled monoclonal antibodies forming antigen-antibody complexes measured quantitatively by analyzer.

Sample Type

Serum / Plasma / Whole Blood

Sample Volume

100 µL

Test Time

15 minutes

Measuring Range

2 – 1000 U/mL

Detection Limit

≤2 U/mL

Technology

Fluorescence Immunoassay

Compatible Analyzers

GETEIN 1100
GETEIN 1160

Storage & Stability

Store at 4–30°C with shelf life up to 24 months.

Applications

Oncology diagnostics, pancreatic cancer monitoring, gastrointestinal tumor assessment, hospital laboratories and diagnostic centers.